Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-11

FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Quinn Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for Tenofovir disoproxil fumarate from Quinn Pharmaceuticals, granting approval of its generic product under an ANDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)